Keyphrases
Quantitative PCR
100%
Design Study
100%
Elapsed Time
100%
Test-negative Design
100%
SARS-CoV-2 Infection
100%
Vaccine Injection
100%
BNT162b2 Vaccine
100%
Polymerase Chain Reaction Assay
75%
COVID-19
75%
Vaccination
50%
Time Elapsed
50%
COVID-19 Infection
50%
Arab
25%
Israel
25%
Gradual Increase
25%
Healthcare Organizations
25%
Second Dose
25%
Socioeconomic Status
25%
Confidence Interval
25%
Large Population
25%
Ultra-Orthodox Jews
25%
Electronic Health Records
25%
Infection Risk
25%
Comorbid Conditions
25%
Demographic Groups
25%
Conditional Logistic Regression
25%
Two-dose
25%
Vaccine Dose
25%
Large State
25%
State Mandates
25%
Age Categories
25%
Pfizer-BioNTech BNT162b2
25%
Ageing Demographics
25%
Design Test
25%
Nursing and Health Professions
Infection
100%
Vaccine Efficacy
100%
Severe Acute Respiratory Syndrome
100%
BNT162b2 vaccine
100%
Reverse Transcription Polymerase Chain Reaction
66%
Vaccination Policy
33%
Health Care Organization
16%
Population
16%
Logistic Regression Analysis
16%
Socioeconomic Status
16%
Confidence Interval
16%
Electronic Health Record
16%
Age Groups
16%
Medicine and Dentistry
Infection
100%
Reverse Transcription Polymerase Chain Reaction
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Logistic Regression Analysis
25%
Socioeconomic Status
25%
Population
25%
Electronic Health Record
25%
Age Groups
25%
mRNA Vaccine
25%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
SARS Coronavirus
100%
Vaccination Policy
50%
mRNA Vaccine
25%